Sultan Sadia, Bashar Md Abu, Bazhair Rahma M, Abdurahman Doaa O, Alrehaili Renad A, Ennahoui Meimouna E, Alsulaiman Yasmeen S, Alamri Seba D, Mohamed Elgawhara F A
Clinical Science Department-MBBS Program Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia.
Department of Community and Family Medicine All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India.
Obstet Gynecol Int. 2024 Sep 20;2024:7309041. doi: 10.1155/2024/7309041. eCollection 2024.
Hormonal contraceptives (HCs) are used for birth control, menstrual disturbances, and premenopausal syndrome. Most women stop using hormonal contraceptives due to changes in their mood. The evidence regarding the association of hormonal contraception with depression shows mixed results. Therefore, we aim to establish the association between the use of hormonal contraception and depressive symptoms.
A cross-sectional study was conducted on 326 women of the reproductive age group (15-49 years) attending the family planning unit of the obstetrics and gynecology department of a medical college in Saudi Arabia. Their sociodemographic and medical details along with the current use of any contraceptives (hormonal, nonhormonal, or not using any) with duration were collected. Beck depression inventory-II (BDI-II) was applied to the women to assess for depression along with its severity, and a BDI score of >16 was taken to denote clinical depression. Women were stratified by type of contraceptive used, and its association with depression category was assessed.
A total of 326 consenting eligible women in the age group of 15-49 years were enrolled in the study of which 165 (50.6%) were currently using a hormonal contraceptive and 49 (15.0%) were using a nonhormonal contraceptive and the rest 112 (34.4%) were not using any contraceptives. There was no significant difference in the mean BDI scores (=0.79) and degrees of depression (=0.06) between the HC users and HC nonusers. However, individual symptoms of depression such as sadness (=0.01), reduced libido (=0.0002), feelings of pessimism (=0.02), and failure (=0.003) were found to be significantly higher in the HC users than non-HC users.
We conclude that there was no significant difference in mean depression scores between groups. However, a few individual symptoms of depression were high in HC users suggesting depression as a potential side effect of hormonal contraceptive use.
激素避孕药(HCs)用于避孕、调节月经紊乱和治疗绝经前综合征。大多数女性因情绪变化而停止使用激素避孕药。关于激素避孕与抑郁症之间关联的证据显示出混杂的结果。因此,我们旨在确定激素避孕的使用与抑郁症状之间的关联。
对沙特阿拉伯一所医学院妇产科计划生育科的326名育龄期(15 - 49岁)女性进行了一项横断面研究。收集了她们的社会人口统计学和医学详细信息,以及当前使用任何避孕药具(激素、非激素或未使用任何药具)的情况及使用时长。应用贝克抑郁量表第二版(BDI - II)对女性进行抑郁评估及其严重程度评估,BDI得分>16表示临床抑郁。根据所使用的避孕药具类型对女性进行分层,并评估其与抑郁类别之间的关联。
共有326名年龄在15 - 49岁的符合条件且同意参与研究的女性被纳入研究,其中165名(50.6%)目前正在使用激素避孕药,49名(15.0%)正在使用非激素避孕药,其余112名(34.4%)未使用任何避孕药具。激素避孕药使用者和非使用者之间的平均BDI得分(=0.79)和抑郁程度(=0.06)没有显著差异。然而,发现激素避孕药使用者中悲伤(=0.01)、性欲减退(=0.0002)、悲观情绪(=0.02)和无助感(=0.003)等个体抑郁症状明显高于非使用者。
我们得出结论,两组之间的平均抑郁得分没有显著差异。然而,激素避孕药使用者中一些个体抑郁症状较高,表明抑郁可能是激素避孕药使用的潜在副作用。